Previous studies have shown that c-MET mediates chemoresistance to cisplatin in osteosarcoma and that miR-152 acts as a tumor suppressor by targeting c-MET in oral squamous cell carcinoma (65, 66). This evidence concerns the gene MET and neoplasm.